Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Path BioAnalytics
Chapel Hill, North Carolina, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Path BioAnalytics has developed a precision medicine platform using organoid and AI technologies to model patient-specific drug response with a focus on respiratory and GI diseases. Current pipeline consists of small molecule preclinical programs.
- Therapeutic areas
- Infectious DiseasesPulmonologyGastroenterology
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Partnerships
Mission Cure Capital (investment, strategic biobank support)
Beyond the preview
Go deeper on Path BioAnalytics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Path BioAnalytics.